Cite
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol
MLA
Pathologie Pathologen staf, et al. Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1443012563&authtype=sso&custid=ns315887.
APA
Pathologie Pathologen staf, Cancer, Pathologie Moleculair, MS Medische Oncologie, Brain, Spiekman, I. A. C., Geurts, B. S., Zeverijn, L. J., de Wit, G. F., van der Noort, V., Roepman, P., de Leng, W. W. J., Jansen, A. M. L., Kusters, B., Beerepoot, L. V., de Vos, F. Y. F. L., de Groot, D.-J. A., de Groot, J. W. B., Hoeben, A., … Verheul, H. M. W. (2024). Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
Chicago
Pathologie Pathologen staf, Cancer, Pathologie Moleculair, MS Medische Oncologie, Brain, Ilse A C Spiekman, Birgit S Geurts, et al. 2024. “Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1443012563&authtype=sso&custid=ns315887.